TickerFactsScreenerDevelopers

Kymera Therapeutics, Inc. (KYMR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2019: $17.91M2020: $88.13M2021: -$128.95M2022: -$153.09M2023: -$102.83M2024: -$194.50M2025: -$232.89M-$232.89M
2019Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$232.89M-19.7%
2024-$194.50M-89.2%
2023-$102.83M+32.8%
2022-$153.09M-18.7%
2021-$128.95M-246.3%
2020$88.13M+392.2%
2019$17.91M—